ear-infrared fluorescence imaging using indocyanine green as an adjunct to improve standard-of-care sentinel lymph node procedure in pediatric patients with melanoma or sarcoma of head/neck/trunk, paratesticular or extremities: a feasibility trial - ICG to improve sentinel lymph node procedure in pediatric patients

Princess Maxima Center for pediatric oncology0 个研究点目标入组 22 人开始时间: 2020年4月15日最近更新: 2023年11月13日

适应症

试验速览

暂无简介。

•Pediatric patients with melanoma or sarcoma of head/neck/trunk, paratesticular or extremities that have an indication for a sentinel node procedure.
•Age 0-18 years.
•Written informed consent from patient/parents/legal guardians, according to local law and regulations.
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 22
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•1. Allergy to iodine
•2 Hypersensitivity to ICG
•3. Kidney insufficiency (eGFR<55)
•4. Clinical manifest hyperthyroidism/ autonomous thyroid adenoma
•5. Nanocolloid or shell fish allergy (same as in standard care: or Technetium-nanocolloid use)

发起方

Princess Maxima Center for pediatric oncology